Depressive disorder, major Trials in O'Fallon, United States
Conditions / Depressive disorder, major / O'Fallon, United States
Clinical trials for Depressive disorder, major investigate a range of treatment strategies and patient populations.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02951988 | A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT06558344 | A Study to Test Different Doses of BI 1569912 in People With Depression | COMPLETED | PHASE2 |
| NCT03002077 | Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT04513912 | A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy | COMPLETED | PHASE3 |
| NCT03668600 | Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD) | TERMINATED | PHASE3 |
| NCT02709746 | Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD) | COMPLETED | PHASE3 |
| NCT04521478 | A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression | COMPLETED | PHASE2 |
| NCT05455684 | A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy | COMPLETED | PHASE3 |
| NCT05518149 | A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) | TERMINATED | — |
| NCT02943577 | A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03) | COMPLETED | PHASE3 |